Dr. Saranya Reghunathan, MD

Dr. Reghunathan practices at Advanced ENT & Voice Center in Camarillo, California.

Dr. Reghunathan's NPI, 1811252968, was assigned on July 5, 2012. Dr. Reghunathan holds California license A162142.

Dr. Reghunathan's primary practice is Advanced ENT & Voice Center, at 3687 Las Posas Rd Ste 187h, Camarillo, CA 93010-1431. The practice phone is (805) 309-0818.

Dr. Reghunathan's primary practice is Advanced ENT & Voice Center in Camarillo, California. Dr. Reghunathan is also affiliated with Community Memorial Hospital - Ventura. Dmand AI also links Dr. Reghunathan to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reghunathan practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Reghunathan's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Reghunathan is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Reghunathan's licenses on file in 2 states: California and Ohio.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Reghunathan treats.

CMS data shows 1,161 Medicare services from Dr. Reghunathan across 16 procedure codes in 2024, for 180 Medicare patients. Medicare paid $528,642 for them.

CMS counts 180 Medicare patients who saw Dr. Reghunathan in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Reghunathan's median patient age at 59, with 57% women.

In 2024, Dr. Reghunathan wrote 289 Medicare Part D claims for 100 patients. 99% of them were for generic drugs. CMS names the drug for 230 of them, across 8 drugs with 11 or more claims each, at $2,363 in total drug cost. In 2023, CMS named 303 claims across 7 drugs.

Dr. Reghunathan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Reghunathan, published from 2014 to 2019. 2014 was the busiest year, with 2. The most frequent topics are Hearing Aids. Dr. Reghunathan has published most often in Otol Neurotol. Dr. Reghunathan's most frequent co-authors are Abraham Jacob, MD, Paul Bryson, MD and Erynne Azalea Faucett, MD.

CMS Open Payments shows 78 general payments to Dr. Reghunathan from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Stryker Corporation paid the most, $1,955.

Dr. Reghunathan is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.